Nicola P. Klein
Publications by Year
Research Areas
Vaccine Coverage and Hesitancy, Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, Bacterial Infections and Vaccines, Respiratory viral infections research
Most-Cited Works
- → Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents(2021)921 cited
- → Surveillance for Adverse Events After COVID-19 mRNA Vaccination(2021)632 cited
- → Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children(2012)572 cited
- → Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings(2021)498 cited
- → Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022(2022)468 cited
- → Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022(2022)428 cited
- → Risk of anaphylaxis after vaccination in children and adults(2015)379 cited
- → The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety(2011)345 cited
- → Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures(2010)311 cited
- → The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors.(1995)310 cited